A Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle OA
Efficacy and Safety of a Single Intraarticular Injection of Platelet-Rich Plasma on Pain and Physical Function in Patients With Ankle Osteoarthritis-a Prospective Study
1 other identifier
interventional
44
1 country
1
Brief Summary
Platelet-rich plasma (PRP) has been reported to be an effective treatment for knee osteoarthritis (OA). The application in ankle OA has rarely been investigated. The aim was to evaluate the efficacy and safety of a single intraarticular injection of PRP for the treatment of patients with ankle OA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2019
CompletedFirst Submitted
Initial submission to the registry
July 11, 2019
CompletedFirst Posted
Study publicly available on registry
July 17, 2019
CompletedJuly 19, 2019
July 1, 2019
5 months
July 11, 2019
July 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual analog scale (VAS) of ankle pain
The patient rated the average severity of ankle pain on ankle movement over the previous week on a 10-cm VAS (0=no pain to 10=worst possible pain)
6 months
Secondary Outcomes (6)
The Ankle Osteoarthritis Scale (AOS) score
6 months
The American Orthopedic Foot and Ankle Society (AOFAS) ankle/hindfoot score
6 months
The single-leg stance (SLS) test
6 months
use of analgesic medication
through study completion, an average of 6 months
global satisfaction
6 months
- +1 more secondary outcomes
Study Arms (1)
PRP injection
EXPERIMENTALPatients with symptomatic ankle OA for at least 6 months were recruited. Patients received a single injection of 3-ml of PRP into symptomatic ankles.
Interventions
, For PRP preparation, specialized platelet concentrate separator containing acid citrate dextrose as anticoagulant and a specific separator gel that harvest PR, preventing contamination of red blood cells and leukocytes were used.
Eligibility Criteria
You may qualify if:
- Age of at least twenty years
- Ankle pain lasted for at least 6 months, despite conservative treatment or inability to tolerate the side effects of medications
- Ankle radiographs taken within 6 months (reviewed by the senior author) were equivalent to grade 1-4 osteoarthritis by the Kellgren Lawrence grading system
- Average ankle pain of \> 3cm on a 10-cm visual analog scale (VAS)
- Radiological evidence of bilateral ankle osteoarthritis was accepted if VAS pain in the contralateral ankle was \< 3 cm
- Normal activity level, not bedridden or confined to a wheelchair, able to walk 30 meters without the aid of a walker, crutches or cane
- No use of physical therapy or changes in shoes or orthotic devices during the study
You may not qualify if:
- Pregnancy or lactation in women
- Lower leg trauma in a location other than within the ankle
- Previous surgery involving the spine, hip or knee
- The presence of an active infection of the ankle
- Surgery involving the affected ankle within the previous 12 months
- Intraarticular steroid or hyaluronate injection in the ankle within the previous 6 months
- Treatment with anticoagulants or immunosuppressives
- History of rheumatoid arthritis, gout, or other inflammatory arthropathy
- The presence of visual or vestibular impairments
- Poor health status (such as a neoplasm, diabetes mellitus, or paresis) that would interfere with the assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Physical Medicine and Rehabilitation, Veterans General Hospital Kaohsiung
Kaohsiung City, 813, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shu Fen Sun, MD
Kaohsiung Veterans General Hospital, Taiwan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Neutorehabilitation, MD,Department of Physical Medicine and Rehabilitation, Kaohsiung Veterans General Hospital
Study Record Dates
First Submitted
July 11, 2019
First Posted
July 17, 2019
Study Start
July 1, 2018
Primary Completion
November 30, 2018
Study Completion
May 30, 2019
Last Updated
July 19, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share